Elaboración de un listado cuantitativo de especialidades medicinales para pacientes con epilepsia refractaria en tratamiento con dieta cetogénica
Keywords:
Excipientes, Dieta cetogénica, Epilepsia reflactaria, Hidratos de carbonoAbstract
Background
The ketogenic diet (KD) constitutes a non-pharmacological treatment for management of refractory epilepsy. This diet is based on variations in the relationships between lipids and carbohydrates (CH) + proteins (4:1 o 3:1). Because is a restricted diet in carbohydrates and its used in polymedicated patients we must take into consideration the contribution of CH of the excipients.
Objective
Identify the most commonly prescribed active ingredients (AI) in patients with KD and make a list of the medicinal specialties (MS) of each one detailing their contribution of CH.
Materials and Methods
We performed a descripted, prospective, observational and cross-sectional study of the most commonly prescribed active ingredients in patients with KD in our hospital in two complementary stages. The study was made from July 2018 to July 2019 and included the MS that were once part of our stock. The ME were classified in: complete qualitative-quantitative formula (CQQF), only qualitative formula (OQF), without formula (WF) and without leaflet (WL). A percentage statistical analysis was performed. The obtained information was summarized on an Excel table.
Results
We analyzed 47 AI, 728 MS and 80 laboratories.
The results of each stage were: CQQF 57,7% and 81,9%; OQF 34,5% and 14,6%; NF 6,7 and 2,7%; NL 1,1 and 0,8%; respectively. It was found that 13.9% of the MS were CH free.
Conclusion
We found that the percentage of CH free MS was low. However we obtained a consultation table containing the contribution of CH from MS.
References
- Marisa Armeno, Roberto Cara bailo, María Vaccarezza, M. Julia Alberti, Viviana Ríos, Santiago Gallcch!, et al. Consenso nacional sobre dieta cetogénica. Rev Neurol 2014; 59 (5): 213-223.
- Cinqui G, Lorenzini L, Armeno M, Araujo C, Perez M. Dieta cetogénica. Boletín N°39 CIME, Servicio de Farmacia Htal. Garrahan. Enero 2017. Disponible en: http://www.garrahan.gov.ar/PDFS/cime/ dieta_cetogenica.pdf
- Alberti MJ, Borras Iglesias R, Díaz Basanta S, Iribarne M, Moriones E, Sanchez A, et al. Dieta cetogénica como alternativa terapéutica en epilepsia refractaria. 10 años de experiencia. Comunicación libre N° 4476. Conarpe 2019. Sociedad Argentina de Pediatría.
- Armeno M, Araujo C, Caraballo R. Mantenimiento de la dieta cetógena. En Caraballo R. Dieta cetógena en el tratamiento de la epilepsi. 1ra ed.- Ciudad Autónoma de Buenos Aires: Journal 2017. p 35-54.
- Vidal CJ. Sobre la alerta de la Food and Drug Administration (FDA) en relación con valores erróneos de glucemia por interferencia de otros azúcares. JANO,N°. 1762, 2010, p 61.
- Vademecum Nacional de medicamentos de ANMAT, disponible en: https://servicios.pami.org.ar/ vademecum/views/consultaPublica/listado.zul
- Disposición ANMAT N° 5904/1996. Disponible en: http://www.anmat.gov.ar/webanmat/ NORMA TIVA/NORMA TIVA/MEDICAMENTOS/DISPOSICION_ANMA T_5904-1996. PDF
